Carcinoma, Hepatocellular: all 3,249 studies

Page 28 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.

• Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular CarcinomaCompletedNCT02031952Not applicable
• A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC)CompletedNCT02029157Phase 3
• Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).SuspendedNCT02026362Phase 1/2
• Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular CarcinomaCompletedNCT02025842
• Influence of Probiotics Administration Before Liver Resection in Liver DiseaseCompletedNCT02021253Not applicable
• Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCCStatus unknownNCT02018757Phase 2
• Laparoscopic Hepatectomy Versus Open Hepatectomy for PHCCompletedNCT02014025Not applicable
• Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By SurgeryCompletedNCT02013492Early Phase 1
• Laparoscope Anatomical and Aon-anatomical HepatectomyStatus unknownNCT02009176Not applicable
• to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)CompletedNCT02008929Phase 2
• Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT02006030Phase 2
• A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular CarcinomaWithdrawnNCT02004210Phase 3
• Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With YttriumCompletedNCT02003339Not applicable
• A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCCStatus unknownNCT01997957Phase 4
• An Individualized Anti-Cancer Vaccine Study in Patients With HCCWithdrawnNCT01995227Phase 1/2
• Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular CarcinomaCompletedNCT01974661Phase 1
• The Phase II Study of Icaritin in Patients With Advanced Hepatocellular CarcinomaCompletedNCT01972672Phase 2
• 24hr Imaging Of HCC After EOVISTWithdrawnNCT01968629Early Phase 1
• TACE as an Adjuvant Therapy After Hepatectomy for HCCStatus unknownNCT01966133Phase 3
• Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT01964235Phase 2
• The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver CancerCompletedNCT01964001Phase 2/3
• Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable EventsWithdrawnNCT01963949
• Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCCCompletedNCT01963429Not applicable
• A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine GreenCompletedNCT01962649Early Phase 1
• PLA for HCC and Esophageal ca SerumStatus unknownNCT01957241
• Study of High-Dose Oral Vitamin D for the Prevention of Liver CancerWithdrawnNCT01956864Phase 1
• The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular CarcinomaWithdrawnNCT01953406Phase 2
• Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous InvasionCompletedNCT01952353Phase 4
• Boramae Hospital Liver Cirrhosis Patient Cohort StudyCompletedNCT01943318
• A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)TerminatedNCT01942083Phase 1
• Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the LimitsCompletedNCT01937286
• Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical SurgeryStatus unknownNCT01936233Phase 3
• Urea Cream Treatment Sorafenib-Associated HSFR in HCCCompletedNCT01934829Phase 2
• Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by SorafenibCompletedNCT01933945
• Sorafenib in Liver Function Impaired Advanced Hepatocellular CarcinomaCompletedNCT01932385Phase 2/3
• Circulating Tumor Cells for Hepatocellular CarcinomaStatus unknownNCT01930383
• Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular CarcinomaStatus unknownNCT01924624Not applicable
• Preoperative Pain Control in Liver Surgery PatientsCompletedNCT01923948Not applicable
• In-Situ Therapeutic Cancer Vaccine for Refractory Liver CancerWithdrawnNCT01923233Phase 1/2
• TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC PatientsActive, not recruitingNCT01918683Not applicable
• Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)CompletedNCT01915602Phase 2
• Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)CompletedNCT01915589Phase 2
• Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor ThrombosisCompletedNCT01911000Phase 2
• Stereotactic Body Radiotherapy for Unresectable Hepatocellular CarcinomaCompletedNCT01910909Not applicable
• Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and SafetyCompletedNCT01908322
• Sorafenib Chemoembolization Evaluation Controlled TrialCompletedNCT01906216Phase 3
• Study of Hepatocellular Carcinoma in Cirrhotic PatientsCompletedNCT01904942
• Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular InvasionCompletedNCT01901692Phase 2/3
• Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCCCompletedNCT01897610Phase 2
• A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular CarcinomaCompletedNCT01897038Phase 1
• Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With CancerCompletedNCT01896778Not applicable
• Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA ReplicationStatus unknownNCT01894269Phase 4
• VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated PathwayStatus unknownNCT01892072
• Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular CarcinomaStatus unknownNCT01891539
• Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.CompletedNCT01890291
• Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular CarcinomaTerminatedNCT01872988Phase 3
• TACE Plus Recombinant Human Adenovirus for Hepatocellular CarcinomaStatus unknownNCT01869088Phase 3
• Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular CarcinomaStatus unknownNCT01861912Phase 2/3
• Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular CarcinomaStatus unknownNCT01860222Not applicable
• Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm PatientStatus unknownNCT01858207Phase 2
• Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein InvasionWithdrawnNCT01857726Not applicable
• Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaCompletedNCT01850667Phase 2
• Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein InvasionCompletedNCT01850368Phase 2
• Hepatocellular Carcinoma Using Stereotactic Body RadiotherapyStatus unknownNCT01850316Not applicable
• Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on SorafenibActive, not recruitingNCT01840592Phase 2
• Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in ChinaCompletedNCT01839630
• Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)CompletedNCT01837381Not applicable
• P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.Status unknownNCT01834963Phase 2
• Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular CarcinomaCompletedNCT01833299Phase 3
• TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular CarcinomaStatus unknownNCT01833286Phase 3
• The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) StudyWithdrawnNCT01831037
• A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCCCompletedNCT01829035Phase 3
• Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE TherapyCompletedNCT01828762Not applicable
• Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cmStatus unknownNCT01825824Phase 2
• A Study of DC-CIK to Treat Hepatocellular CarcinomaStatus unknownNCT01821482Phase 2
• Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular CarcinomaTerminatedNCT01817205Not applicable
• Autologous Natural Killer T Cells Infusion for the Treatment of CancerStatus unknownNCT01801852Not applicable
• A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)WithdrawnNCT01801163Phase 1
• Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic PatientsCompletedNCT01798173Not applicable
• Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).CompletedNCT01798160Phase 4
• The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related GeneCompletedNCT01786980
• Body Composition Analysis in Patients Undergoing ChemoembolizationCompletedNCT01777698
• Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular CarcinomaCompletedNCT01777594Phase 2
• Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular CarcinomaStatus unknownNCT01768741Not applicable
• Utility Study of Primovist-MRI on HCC StagingStatus unknownNCT01764438
• Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical HepatectomyTerminatedNCT01760616Phase 4
• Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular CarcinomaCompletedNCT01759901Not applicable
• A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular CarcinomaStatus unknownNCT01758679Phase 4
• Sorafenib for Residue Disease After Resection With Curative IntentCompletedNCT01751763
• CIK Treatment for HCC Patient Underwent Radical ResectionCompletedNCT01749865Phase 3
• Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular CarcinomaStatus unknownNCT01747642Phase 2/3
• Analysis of Body Composition in Patients With Hepatocellular Carcinoma in RadioablationWithdrawnNCT01744639Not applicable
• A Phase 1 Study of MM-141 in Patients With Advanced Solid TumorsCompletedNCT01733004Phase 1
• Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.Status unknownNCT01729221
• Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy (ALPPS) or Portal Vein Occlusion in Treating Patients With Liver CancerWithdrawnNCT01722175Phase 2
• TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular CarcinomaStatus unknownNCT01721941Phase 1
• Hepatocellular Carcinoma Treated With Iodine-125 ImplantationCompletedNCT01717729Phase 3
• the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular CarcinomaCompletedNCT01717066Not applicable
• Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPaseStatus unknownNCT01715532Phase 2
• Optimization of Health Expenditure in Liver SurgeryCompletedNCT01715402

← Carcinoma, Hepatocellular overview